Status:
COMPLETED
Memantine in Patients With Chronic Glaucoma
Lead Sponsor:
Allergan
Conditions:
Open-Angle Glaucoma
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
Randomized double-masked clinical trial of memantine in patients with glaucoma
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Glaucoma damage on examination of visual field and optic disc
- Good visual acuity (with glasses if needed)
Exclusion
Key Trial Info
Start Date :
March 1 1999
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2006
Estimated Enrollment :
1119 Patients enrolled
Trial Details
Trial ID
NCT00141882
Start Date
March 1 1999
End Date
August 1 2006
Last Update
November 4 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.